GenSci

CN

1
/
R&D

R&D

R&D

GenSci is dedicated to serving patients wholeheartedly and to providing high-quality products.

imgboxbg

GenSci is dedicated to serving patients wholeheartedly and to providing high-quality products.

imgboxbg

At present, GenSci has more than 16 projects in the preclinical stage, and 8 projects are undergoing clinical stage. Therapeutic fields include growth and development, assisted reproduction, tumor, immune, antiviral and metabolic diseases, etc...

imgboxbg

GenSci059 was granted for clinical trial license by NMPA in September 2020 and Study May Proceed by US FDA in December 2020. It is deemed a milestone marked GenSci’s R&D project in conformity to international...

 

Messages

CONTACT US

Tel:+86-431-85195060

Our Email:

PV: adr@genscigroup.com

Inquiry: webmaster@genscigroup.com

Distributionship:info@genscigroup.com

QUICK NAVIGATION

Copyright: Changchun GeneScience Pharmaceutical Co., Ltd.   吉ICP备14004136号

Copyright: Changchun GeneScience Pharmaceutical Co., Ltd.

吉ICP备14004136号